AKT1 and Sepsis: While our findings demonstrate that lycopene attenuates sepsis-associated renal injury via the PI3K/AKT/Nrf 2 pathway in a CLP model, translating these preclinical results to clinical application requires careful consideration of human dosing and bioavailability.